Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan

Br J Dermatol. 1999 Nov;141(5):935-6. doi: 10.1046/j.1365-2133.1999.03179.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Chemotherapy, Cancer, Regional Perfusion
  • Female
  • Humans
  • Leg* / pathology
  • Leiomyosarcoma / drug therapy*
  • Leiomyosarcoma / pathology
  • Melphalan / therapeutic use*
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / pathology
  • Tumor Necrosis Factor-alpha / therapeutic use*

Substances

  • Antineoplastic Agents, Alkylating
  • Tumor Necrosis Factor-alpha
  • Melphalan